Forte Biosciences' Future In Doubt After Only Product Fails

Microbiome Product Missed Phase II Endpoints

Illustration of bacteria on colorful background, model of bacteria, microbes, microorganisms,
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D